Enhabit Inc. investigated for potential sale to Kinderhook Industries
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 23 2026
0mins
Should l Buy EHAB?
Source: moomoo
Enhabit Inc. shares rose by 3.00% and reached a 52-week high during regular trading.
The increase in Enhabit’s stock price comes amid an investigation by Halper Sadeh LLC regarding its potential sale to Kinderhook Industries for $13.80 per share. This investigation is part of a broader effort to protect shareholder rights and ensure fair treatment in corporate transactions.
This investigation may lead to increased scrutiny of the sale process and could impact shareholder confidence, as investors seek clarity on the implications of the transaction.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EHAB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EHAB
Wall Street analysts forecast EHAB stock price to fall
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 13.740
Low
10.50
Averages
12.20
High
14.00
Current: 13.740
Low
10.50
Averages
12.20
High
14.00
About EHAB
Enhabit, Inc. is a provider of home health and hospice services in the United States. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. It works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. It operates about 115 hospice agencies and 255 home health agencies.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

- Investigation Background: Halper Sadeh LLC is investigating TruBridge, Inc. (NASDAQ: TBRG) regarding its sale to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, which may infringe on shareholder rights.
- Transaction Terms Risk: Marine Products Corporation (NYSE: MPX) is being sold to MasterCraft Boat Holdings, Inc. for $2.43 per share in cash and 0.232 shares of MasterCraft common stock, with terms that could limit superior competing offers.
- Shareholder Rights Protection: Enhabit, Inc. (NYSE: EHAB) is selling to Kinderhook Industries, LLC for $13.80 per share in cash, and Halper Sadeh LLC encourages shareholders to discuss their rights and options at no cost or obligation.
- Merger Impact: The merger between MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) and Marine Products Corporation will result in MasterCraft shareholders owning 66.5% of the combined company, with Halper Sadeh LLC potentially seeking increased compensation and disclosures for shareholders.
See More
- Investigation Focus: Halper Sadeh LLC is investigating Clear Channel Outdoor Holdings, Inc. (NYSE:CCO) for potential fiduciary duty breaches related to its sale to Mubadala Capital and TWG Global at $2.43 per share, which may disadvantage shareholders.
- Shareholder Rights: Enhabit, Inc. (NYSE:EHAB) is being sold to Kinderhook Industries, LLC for $13.80 per share in cash, prompting Halper Sadeh LLC to encourage shareholders to inquire about their rights and options, potentially impacting the transparency and fairness of the transaction.
- Potential Gains: Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is selling to Biogen Inc. for $41.00 per share in cash plus two non-transferable contingent value rights of $2.00 each, contingent on meeting specific sales thresholds, which may limit superior competing offers.
- Legal Support: Halper Sadeh LLC represents investors globally, seeking increased consideration and additional disclosures to ensure that the legal rights of affected shareholders are upheld and that they receive appropriate remedies for any corporate misconduct.
See More

- Investigation Background: Halper Sadeh LLC is investigating Enhabit, Inc. (NYSE:EHAB) regarding its sale to Kinderhook Industries, LLC for $13.80 per share, which may infringe on shareholder rights, prompting shareholders to understand their rights and options.
- UniFirst Transaction Details: UniFirst Corporation (NYSE:UNF) is being sold to Cintas Corporation for $155.00 in cash and 0.7720 shares of Cintas stock per UniFirst share, with Halper Sadeh LLC advising shareholders to be aware of potential legal rights and remedies.
- Airline Merger: Sun Country Airlines Holdings, Inc. (NASDAQ:SNCY) is being sold to Allegiant Travel Company for 0.1557 shares of Allegiant common stock and $4.10 in cash per Sun Country share, with Halper Sadeh LLC encouraging shareholders to consult to protect their rights.
- Merger Investigation: The merger of Esquire Financial Holdings, Inc. (NASDAQ:ESQ) with Signature Bancorporation, Inc. is also under investigation, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures for shareholders.
See More
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the transaction between Whitestone REIT and Ares Management, with Whitestone shareholders expected to receive $19.00 per share in cash, significantly enhancing shareholder returns on their investments.
- Assertio Transaction Details: In the deal between Assertio Holdings and Garda Therapeutics, shareholders are expected to receive $18.00 in cash per share plus a contingent value right based on specific milestones, a structure that may attract more investor interest in the company's future growth potential.
- Enhabit Shareholder Vote: Enhabit Inc.'s transaction with Kinderhook Industries is expected to provide shareholders with $13.80 per share in cash, with the shareholder vote scheduled for May 12, 2026, a critical date that will influence the final outcome of the transaction.
- Select Medical Transaction Overview: Shareholders of Select Medical Holdings Corporation are expected to receive $16.50 per share in cash, with the transaction led by Select Medical executives and directors, a structure that may enhance governance transparency and increase shareholder trust.
See More
- Investigation Background: Halper Sadeh LLC is investigating Enhabit, Inc. (NYSE: EHAB) regarding its sale to Kinderhook Industries, LLC for $13.80 per share in cash, potentially infringing on shareholder rights, aiming to ensure fair treatment for investors.
- Shareholder Rights Protection: The law firm encourages Enhabit shareholders to reach out to discuss their rights and options, emphasizing the provision of legal consultations at no cost, ensuring shareholders are not overlooked in the transaction.
- Other Company Investigations: The inquiry also covers Whitestone REIT (NYSE: WSR) with Ares Management Corporation at $19.00 per unit, and Select Medical Holdings Corporation (NYSE: SEM) with its management for $16.50 per share, highlighting a focus on shareholder interests.
- Legal Remedies: Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief measures to protect investors' rights, reflecting a commitment to securities law and fiduciary responsibilities.
See More
- Investigation Focus: Halper Sadeh LLC is investigating Enhabit, Inc. (NYSE:EHAB) for its sale to Kinderhook Industries, LLC at $13.80 per share in cash, potentially violating fiduciary duties and impacting shareholder rights.
- Potential Violations: The firm is also scrutinizing Silicon Laboratories Inc. (NASDAQ:SLAB) for its sale to Texas Instruments at $231.00 per share in cash, which may limit superior competing offers and harm ordinary shareholders' interests.
- Shareholder Rights Protection: The investigation extends to Penumbra, Inc. (NYSE:PEN), which is being sold for $374.00 in cash or 3.8721 shares of Boston Scientific common stock, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures for shareholders.
- Legal Service Commitment: SkyWater Technology, Inc. (NASDAQ:SKYT) is under review for its sale at $15.00 in cash and $20.00 in IonQ common stock, with Halper Sadeh LLC promising no upfront legal fees to protect shareholder rights.
See More









